"I am glad that taking part in a trial might help others on their own cancer journey.”
A trial looking at gemcitabine and cisplatin for advanced bladder cancer
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
This trial looked at gemcitabine and cisplatin chemotherapy for bladder cancer that had come back after treatment or spread to another part of the body.
The aims of the trial were to find out
- The best dose of gemcitabine and cisplatin to use
- More about the side effects
- How well this combination worked for advanced bladder cancer
Summary of results
The research team found that the combination of gemcitabine and cisplatin chemotherapy is useful for treating advanced bladder cancer.
This trial recruited 32 patients aged 41 to 79 with advanced bladder cancer.
- In 4 people the cancer went away - researchers call this ‘
- In 17 people the cancer slowed or stopped growing - researchers call this ‘
- In 6 people the cancer remained the same - researchers call this ‘
- 1 person’s cancer continued to grow
- They did not have results for 4 people
The most common side effect was a drop in blood cell counts.
We have based this summary on information from the team who ran the trial. The information they sent us has been reviewed by independent specialists (
How to join a clinical trial
Professor Nick James
University of Birmingham